Impact Biomedical (IBO) Intangibles (2022 - 2026)

Impact Biomedical (IBO) has reported Intangibles for 5 consecutive years, with $22.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Intangibles changed 0.37% year-over-year to $22.6 million; the trailing twelve-month figure through Jun 2026 stood at $22.6 million (changed 0.37% YoY), and the FY2025 full-year result was $22.6 million, up 1.46% from the prior year.
• Intangibles was little changed at $22.6 million in Q2 2026 per IBO's latest filing, from $22.6 million in the prior quarter.
• Across five years, Intangibles topped out at $22.7 million in Q2 2025 and bottomed at $22.3 million in Q4 2022.
• Historically, Intangibles has averaged $22.4 million across 5 years, with a median of $22.3 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Intangibles grew 1.84% in 2025, then fell 0.37% in 2026.
• Over 5 years, Intangibles stood at $22.3 million in 2022, then changed by 0.0% to $22.3 million in 2023, then changed by 0.0% to $22.3 million in 2024, then advanced by 1.46% to $22.6 million in 2025, then changed by 0.0% to $22.6 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $22.6 million, $22.6 million, and $22.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.